Local pharma formulators to benefit from new USFDA generic guidance: Report

This will help domestic pharma formulators with pending ANDA approvals to reduce review cycles and expedite approvals, says a weekend report by India Ratings.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news